PROS1 and salivary gland disorder: The knowledge obtained may guide the development of treatment and management strategies for post-COVID-associated salivary gland disease by targeting S protein, its interaction with epithelial cells (e.g., S protein-TLR2/4 axis), and downstream inflammatory cascades.